Coronation Fund Managers’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-376,355
Closed -$11.1M 174
2023
Q4
$11.1M Buy
376,355
+21,451
+6% +$445K 0.31% 75
2023
Q3
$7.37M Buy
354,904
+147,058
+71% +$4.04M 0.22% 88
2023
Q2
$5.1M Buy
207,846
+57,501
+38% +$1.85M 0.14% 116
2023
Q1
$6.11M Sell
150,345
-34,799
-19% -$1.44M 0.16% 110
2022
Q4
$8.32M Buy
+185,144
New +$8.38M 0.23% 88

Other funds holding TNDM

Coronation Fund Managers's TNDM Position: Q1 2024 in Review

Coronation Fund Managers sold out of Tandem Diabetes Care (TNDM) in Q1 2024, closing a stake of 376,355 shares — an estimated $11.1M sold.

Coronation Fund Managers first reported a position in TNDM in Q4 2022 and held it in 5 quarters. The position peaked at $11.1M in Q4 2023. 291 funds tracked by Wall St. Rank hold TNDM as of Q1 2024.

  • Coronation Fund Managers reported no remaining Tandem Diabetes Care position as of Q1 2024 after selling out during the quarter.
  • Coronation Fund Managers sold 376,355 Tandem Diabetes Care shares in Q1 2024, an estimated $11.1M.
  • Coronation Fund Managers first reported a position in Tandem Diabetes Care in Q4 2022 and held it in 5 quarters.
  • Coronation Fund Managers's Tandem Diabetes Care position peaked at $11.1M in Q4 2023.
  • 291 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2024.

Based on Coronation Fund Managers's 13F filing for Q1 2024, filed 3 May 2024.